详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Little Antimicrobial Peptides with Big Therapeutic Roles.

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University / Collaborative Innovation Center for Biotherapy, Chengdu 610041, P.R. China [2]Department of Urinary Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, P.R. China [3]Laboratory of Cell and Molecular Biology, State Key Laboratory of Molecular Oncology, Cancer Institute & Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100034, P.R. China

出处：

DOI：

ISSN：

关键词： Antimicrobial peptides bioactivity molecular mechanisms therapeutic potential anticancer activity antibacterial

摘要：

Antimicrobial Peptides (AMPs) are short amphipathic biological molecules generally with less than 100 amino acids. AMPs not only present high bioactivities against bacteria, fungi or protists-induced infections, but also play important roles in anticancer activity, immune response and inflammation regulation. AMPs are classified as ribosomally synthesized, non-ribosomally synthesized and post-translationally modified, non-ribosomally synthesized ones and several synthetic or semisynthetic peptides according to their synthesis with or without the involvement of ribosomes. The molecular characterization and bioactivity action mechanisms are summarized for several ribosomally synthesized AMPs and main non-ribosomally synthesized members (cyclopeptides, lipopeptides, glycopeptides, lipoglycopeptides). We also analyze challenges and new strategies to overcome drug resistance and application limitations for AMP discovery. In conclusion, the growing novel small molecular AMPs have huge therapeutic potentials of antibacterial, antiviral, anticancer and immunoregulatory bioactivities through new techniquesdriven drug discovery strategy including bioinformatics prediction, de novo rational design and biosynthesis. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2019]版：

大类 | 4 区生物学

小类 | 4 区生化与分子生物学

最新[2023]版：

大类 | 4 区生物学

小类 | 4 区生化与分子生物学

第一作者：

第一作者机构： [1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University / Collaborative Innovation Center for Biotherapy, Chengdu 610041, P.R. China

通讯作者：

通讯机构： [1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University / Collaborative Innovation Center for Biotherapy, Chengdu 610041, P.R. China [*1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, No.17, 3rd Section of People's South Road, Chengdu 610041, P.R. China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential [2]CD25: A potential tumor therapeutic target [3]Erianin: A phytoestrogen with therapeutic potential [4]甲状腺未分化癌的分子机制研究 [5]Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma. [6]Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms [7]Honokiol: A review of its pharmacological potential and therapeutic insights. [8]A Novel Imidazopyridine Derivative Exerts Anticancer Activity by Inducing Mitochondrial Pathway-Mediated Apoptosis [9]Role of NSD1 as potential therapeutic target in tumor. [10]Molecular signal networks and regulating mechanisms of the unfolded protein response.